A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread
Clinical trial NCT04147247 · COMPLETED
Trial details
- NCT number
- NCT04147247
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-23
- Primary completion
- 2021-05-06
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.